NOREPINEPHRINE

NOREPINEPHRINE was reported 14748 times

NOREPINEPHRINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 220 0.5685
1 SLEEP DISORDER THERAPY 72 0.3636
2 ANTACID THERAPY 44 0.3385
3 ELECTROCARDIOGRAM T WAVE ALTERNANS 12 0.2791
4 VITAMIN B1 INCREASED 13 0.2766
5 ANALGESIC THERAPY 70 0.2181
6 DIABETIC MACROANGIOPATHY 7 0.2121
7 SCHIZENCEPHALY 9 0.2000
8 DRUG THERAPY 66 0.1947
9 BLOOD LACTIC ACID DECREASED 30 0.1744
10 CARDIAC OUTPUT INCREASED 28 0.1637
11 COVID-19 TREATMENT 11 0.1618
12 CEREBRAL HAEMORRHAGE FOETAL 9 0.1475
13 ANTICOAGULANT THERAPY 41 0.1444
14 SYSTOLIC ANTERIOR MOTION OF MITRAL VALVE 12 0.1429
15 MYOGLOBIN URINE PRESENT 35 0.1423
16 VITAMIN B1 DECREASED 32 0.1275
17 BACTEROIDES INFECTION 30 0.1149
18 CONGENITAL HIATUS HERNIA 25 0.1096
19 SIGMOID SINUS THROMBOSIS 7 0.1061
20 MALIGNANT MELANOMA STAGE 0 22 0.1053
21 PROPOFOL INFUSION SYNDROME 74 0.1050
22 MYOCARDIAL CALCIFICATION 12 0.1026
23 ELECTROCARDIOGRAM U WAVE PRESENT 6 0.0968
24 BURKHOLDERIA TEST POSITIVE 12 0.0968
25 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 29 0.0833
26 ADRENERGIC SYNDROME 6 0.0741
27 VASOPLEGIA SYNDROME 118 0.0719
28 HYPERDYNAMIC LEFT VENTRICLE 16 0.0650
29 CAFE AU LAIT SPOTS 6 0.0600
30 VASCULAR RESISTANCE SYSTEMIC DECREASED 8 0.0597
31 DRY GANGRENE 37 0.0583
32 BLOOD PHOSPHORUS INCREASED 147 0.0538
33 PULMONARY HAEMATOMA 6 0.0513
34 MYOGLOBINAEMIA 6 0.0508
35 GENITAL EROSION 14 0.0471
36 ANION GAP 29 0.0457
37 HYPERPHOSPHATAEMIA 98 0.0455
38 ACID BASE BALANCE ABNORMAL 10 0.0446
39 PULMONARY HYPERTENSIVE CRISIS 12 0.0443
40 PHAEOCHROMOCYTOMA CRISIS 9 0.0425
41 CARDIOGENIC SHOCK 535 0.0372
42 DISTRIBUTIVE SHOCK 82 0.0362
43 HYPERLACTACIDAEMIA 97 0.0361
44 RESPIRATORY GAS EXCHANGE DISORDER 13 0.0350
45 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 13 0.0320
46 MEAN ARTERIAL PRESSURE DECREASED 8 0.0316
47 MYOCARDIAL DEPRESSION 8 0.0310
48 SYSTOLIC DYSFUNCTION 32 0.0304
49 RENAL CORTICAL NECROSIS 7 0.0300
50 GASTROINTESTINAL ISCHAEMIA 8 0.0289
51 HUMAN HERPESVIRUS 6 INFECTION REACTIVATION 10 0.0285
52 PHARYNGEAL HAEMORRHAGE 35 0.0284
53 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 26 0.0280
54 CUTANEOUS MUCORMYCOSIS 5 0.0272
55 CYTOTOXIC OEDEMA 7 0.0264
56 LOCKED-IN SYNDROME 12 0.0260
57 NECROSIS ISCHAEMIC 12 0.0260
58 HAEMODYNAMIC INSTABILITY 195 0.0256
59 DISSEMINATED MUCORMYCOSIS 10 0.0254
60 DIABETES INSIPIDUS 61 0.0253
61 KIDNEY DUPLEX 6 0.0250
62 ELECTROCARDIOGRAM P WAVE ABNORMAL 6 0.0245
63 MULTIPLE ORGAN DYSFUNCTION SYNDROME 693 0.0244
64 APPENDICITIS 225 0.0241
65 LARYNGOMALACIA 8 0.0239
66 EXTREMITY NECROSIS 41 0.0235
67 PNEUMONITIS ASPIRATION 8 0.0234
68 VENTRICULAR FIBRILLATION 256 0.0230
69 PERIPHERAL ISCHAEMIA 94 0.0230
70 DISSEMINATED STRONGYLOIDIASIS 5 0.0228
71 CSF PRESSURE INCREASED 6 0.0226
72 PULSELESS ELECTRICAL ACTIVITY 93 0.0222
73 FOETAL EXPOSURE DURING DELIVERY 15 0.0221
74 TUBERCULOSIS GASTROINTESTINAL 7 0.0219
75 TOTAL LUNG CAPACITY DECREASED 34 0.0213
76 BRONCHOPULMONARY DYSPLASIA 17 0.0211
77 METHAEMOGLOBINAEMIA 48 0.0207
78 CLOSTRIDIAL SEPSIS 5 0.0207
79 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 7 0.0205
80 ISCHAEMIC HEPATITIS 28 0.0204
81 MATERNAL EXPOSURE DURING DELIVERY 20 0.0202
82 PNEUMONIA NECROTISING 13 0.0201
83 VASOCONSTRICTION 17 0.0194
84 STRESS CARDIOMYOPATHY 113 0.0194
85 IRON DEFICIENCY 84 0.0187
86 BLINDNESS CORTICAL 9 0.0184
87 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 15 0.0182
88 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 93 0.0181
89 NECROTISING OESOPHAGITIS 9 0.0180
90 BLOOD URIC ACID INCREASED 104 0.0180
91 ACUTE LUNG INJURY 21 0.0177
92 COMPARTMENT SYNDROME 46 0.0176
93 SHOCK 399 0.0173
94 ANION GAP INCREASED 23 0.0172
95 DILATATION INTRAHEPATIC DUCT ACQUIRED 5 0.0171
96 VENTRICULAR HYPOKINESIA 55 0.0171
97 MYOCARDIAL INJURY 19 0.0169
98 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 85 0.0168
99 DEVICE COMPUTER ISSUE 5 0.0167
100 SYMPTOM MASKED 12 0.0165
101 MUCOSAL EROSION 15 0.0165
102 PROCEDURAL HYPOTENSION 14 0.0165
103 ABDOMINAL COMPARTMENT SYNDROME 10 0.0157
104 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 31 0.0157
105 HYPERTHERMIA MALIGNANT 23 0.0154
106 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 12 0.0154
107 LIMB AMPUTATION 6 0.0151
108 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 16 0.0145
109 DRUG EFFECT PROLONGED 8 0.0145
110 LUNG OPACITY 38 0.0144
111 HYPOPHOSPHATAEMIA 106 0.0143
112 BRASH SYNDROME 20 0.0142
113 JARISCH-HERXHEIMER REACTION 10 0.0140
114 MECHANICAL ILEUS 8 0.0140
115 LABORATORY TEST INTERFERENCE 11 0.0140
116 APALLIC SYNDROME 10 0.0138
117 ACINETOBACTER INFECTION 15 0.0137
118 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 7 0.0137
119 LEFT VENTRICULAR DILATATION 7 0.0137
120 MYASTHENIA GRAVIS 110 0.0136
121 AORTIC STENOSIS 47 0.0135
122 RESPIRATORY TRACT HAEMORRHAGE 8 0.0134
123 NEURODEVELOPMENTAL DISORDER 9 0.0133
124 TROPONIN INCREASED 101 0.0133
125 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 14 0.0132
126 ACIDOSIS 100 0.0131
127 ACUTE RESPIRATORY DISTRESS SYNDROME 230 0.0130
128 EAR MALFORMATION 6 0.0130
129 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 28 0.0127
130 WOLFF-PARKINSON-WHITE SYNDROME 6 0.0127
131 NEONATAL ASPHYXIA 9 0.0127
132 DELAYED GRAFT FUNCTION 9 0.0127
133 APGAR SCORE LOW 16 0.0124
134 NON-CARDIOGENIC PULMONARY OEDEMA 13 0.0123
135 BRAIN DEATH 38 0.0123
136 SUBCUTANEOUS EMPHYSEMA 12 0.0122
137 HEPARIN-INDUCED THROMBOCYTOPENIA 60 0.0122
138 FUNGAL SEPSIS 10 0.0120
139 INTESTINAL ISCHAEMIA 65 0.0118
140 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 39 0.0118
141 RESPIRATORY ACIDOSIS 46 0.0117
142 METABOLIC ACIDOSIS 372 0.0116
143 RETINAL ISCHAEMIA 7 0.0115
144 HYPOPERFUSION 12 0.0114
145 ANAL STENOSIS 6 0.0113
146 BLOOD MAGNESIUM INCREASED 10 0.0111
147 SEPSIS NEONATAL 9 0.0111
148 DYSBIOSIS 9 0.0110
149 CLOSTRIDIUM TEST POSITIVE 24 0.0109
150 SERRATIA INFECTION 8 0.0107
151 SEPTIC SHOCK 465 0.0107
152 TOXIC EPIDERMAL NECROLYSIS 161 0.0106
153 NODAL ARRHYTHMIA 9 0.0105
154 MOTOR DEVELOPMENTAL DELAY 6 0.0104
155 CYTOKINE STORM 7 0.0102
156 OLIGURIA 63 0.0101
157 VENTRICULAR ARRHYTHMIA 37 0.0101
158 LACTIC ACIDOSIS 326 0.0101
159 COMA SCALE ABNORMAL 29 0.0100
160 HYPERCAPNIA 30 0.0100
161 PERFORATION 8 0.0099
162 AMYLASE INCREASED 36 0.0097
163 ATRIOVENTRICULAR BLOCK FIRST DEGREE 42 0.0097
164 NODAL RHYTHM 14 0.0096
165 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 25 0.0095
166 PHIMOSIS 7 0.0095
167 TOXIC ENCEPHALOPATHY 48 0.0095
168 ANURIA 80 0.0093
169 VENTRICULAR TACHYCARDIA 153 0.0093
170 PULSE ABSENT 44 0.0092
171 MUCORMYCOSIS 24 0.0092
172 CARDIOVASCULAR INSUFFICIENCY 15 0.0092
173 ISCHAEMIA 42 0.0091
174 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 24 0.0090
175 CEREBELLAR INFARCTION 15 0.0089
176 ASCITES 260 0.0088
177 PATENT DUCTUS ARTERIOSUS 35 0.0088
178 PUPIL FIXED 15 0.0087
179 INFANTILE APNOEA 7 0.0086
180 FANCONI SYNDROME 12 0.0085
181 ARTERIOSPASM CORONARY 34 0.0085
182 PNEUMATOSIS INTESTINALIS 24 0.0084
183 FUNGAEMIA 13 0.0083
184 CONTINUOUS HAEMODIAFILTRATION 8 0.0082
185 ANTICHOLINERGIC SYNDROME 13 0.0082
186 HEART SOUNDS ABNORMAL 6 0.0080
187 BEZOAR 11 0.0080
188 PLEURITIC PAIN 22 0.0080
189 SEROTONIN SYNDROME 153 0.0080
190 DILATED CARDIOMYOPATHY 8 0.0079
191 GASTROINTESTINAL NECROSIS 23 0.0079
192 ELECTROCARDIOGRAM PR PROLONGATION 6 0.0078
193 KLEBSIELLA INFECTION 39 0.0077
194 CRITICAL ILLNESS 6 0.0077
195 CIRCULATORY COLLAPSE 131 0.0077
196 COLOUR BLINDNESS 7 0.0076
197 BLOOD FIBRINOGEN INCREASED 6 0.0076
198 HAEMOTHORAX 22 0.0076
199 PRODUCT CONTAMINATION MICROBIAL 9 0.0075
200 PULMONARY VALVE STENOSIS 6 0.0075
201 HAEMATOMA MUSCLE 9 0.0075
202 HAEMOPERITONEUM 6 0.0075
203 EMBOLISM ARTERIAL 9 0.0075
204 HYPERVOLAEMIA 37 0.0075
205 ACUTE LEFT VENTRICULAR FAILURE 5 0.0074
206 PERICARDIAL HAEMORRHAGE 16 0.0073
207 DISSEMINATED INTRAVASCULAR COAGULATION 103 0.0073
208 BRADYCARDIA FOETAL 6 0.0072
209 DEVELOPMENTAL HIP DYSPLASIA 6 0.0072
210 RASH MORBILLIFORM 20 0.0072
211 BLOOD LACTIC ACID INCREASED 38 0.0072
212 MYOGLOBIN BLOOD INCREASED 11 0.0072
213 RESPIRATORY DEPRESSION 88 0.0072
214 KLEBSIELLA SEPSIS 8 0.0071
215 BRADYPNOEA 19 0.0070
216 RIGHT VENTRICULAR FAILURE 49 0.0070
217 GANGRENE 42 0.0070
218 NEPHROGENIC DIABETES INSIPIDUS 8 0.0069
219 LOW BIRTH WEIGHT BABY 55 0.0069
220 CARDIAC ARREST 571 0.0069
221 TORSADE DE POINTES 54 0.0069
222 METABOLIC ALKALOSIS 11 0.0069
223 ANTIPHOSPHOLIPID SYNDROME 11 0.0068
224 INTESTINAL PSEUDO-OBSTRUCTION 6 0.0068
225 STRONGYLOIDIASIS 11 0.0068
226 CARDIAC OUTPUT DECREASED 6 0.0068
227 SYSTEMIC CANDIDA 17 0.0068
228 LIVEDO RETICULARIS 14 0.0067
229 CANDIDA SEPSIS 6 0.0067
230 ESCHERICHIA TEST POSITIVE 8 0.0067
231 WRONG PRODUCT ADMINISTERED 45 0.0067
232 ENTEROCOCCAL BACTERAEMIA 7 0.0066
233 MUSCLE NECROSIS 6 0.0066
234 PNEUMOPERITONEUM 12 0.0065
235 RENAL TUBULAR NECROSIS 63 0.0064
236 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 110 0.0064
237 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 38 0.0064
238 MEGACOLON 10 0.0064
239 BRAIN HERNIATION 19 0.0064
240 RIGHT VENTRICULAR DYSFUNCTION 7 0.0063
241 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 163 0.0063
242 BACTERIAL INFECTION 117 0.0063
243 PYELOCALIECTASIS 6 0.0063
244 COAGULOPATHY 104 0.0062
245 PULMONARY SEPSIS 9 0.0062
246 BRADYCARDIA 326 0.0061
247 OPTIC NERVE INJURY 7 0.0060
248 CATHETER SITE HAEMORRHAGE 15 0.0060
249 PNEUMONIA KLEBSIELLA 11 0.0060
250 PROCALCITONIN INCREASED 7 0.0060
251 DEVICE RELATED SEPSIS 12 0.0060
252 VASODILATATION 15 0.0059
253 HYPOXIA 208 0.0059
254 ACUTE RESPIRATORY FAILURE 113 0.0059
255 ELECTROCARDIOGRAM QT PROLONGED 211 0.0059
256 BLOOD PH DECREASED 10 0.0058
257 LONG QT SYNDROME 14 0.0058
258 CARDIOTOXICITY 52 0.0058
259 BRUGADA SYNDROME 6 0.0058
260 BILIARY TRACT DISORDER 8 0.0058
261 KOUNIS SYNDROME 13 0.0057
262 SINUS BRADYCARDIA 55 0.0057
263 CEREBELLAR ATROPHY 5 0.0057
264 FOETAL DISTRESS SYNDROME 12 0.0057
265 SUPRAVENTRICULAR TACHYCARDIA 54 0.0056
266 INTENTIONAL OVERDOSE 360 0.0056
267 CEREBELLAR HAEMORRHAGE 8 0.0056
268 PSEUDOMONAS INFECTION 48 0.0056
269 MULTI-ORGAN DISORDER 11 0.0056
270 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 43 0.0055
271 PNEUMOMEDIASTINUM 10 0.0055
272 PREMATURE DELIVERY 88 0.0055
273 LEFT VENTRICULAR DYSFUNCTION 37 0.0055
274 ANGLE CLOSURE GLAUCOMA 14 0.0055
275 HYPERNATRAEMIA 27 0.0054
276 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 5 0.0054
277 TROPONIN I INCREASED 9 0.0054
278 TONIC CLONIC MOVEMENTS 7 0.0054
279 RESPIRATORY FAILURE 392 0.0054
280 CEREBRAL HAEMATOMA 18 0.0054
281 CRYPTORCHISM 6 0.0053
282 HYPOTENSION 1070 0.0053
283 METABOLIC ENCEPHALOPATHY 16 0.0053
284 ACUTE KIDNEY INJURY 812 0.0053
285 MYOCLONIC EPILEPSY 8 0.0053
286 RESPIRATORY SYMPTOM 15 0.0053
287 MECHANICAL VENTILATION 10 0.0053
288 FIXED ERUPTION 9 0.0052
289 ELECTROCARDIOGRAM ABNORMAL 41 0.0052
290 SPLENIC INFARCTION 9 0.0052
291 SHOCK HAEMORRHAGIC 42 0.0052
292 CARDIOMYOPATHY 76 0.0051
293 PSEUDOMONAL SEPSIS 9 0.0051
294 LEUKOCYTOSIS 93 0.0051
295 HYPOTONIA NEONATAL 8 0.0051
296 BRONCHOPULMONARY ASPERGILLOSIS 39 0.0050
297 SEPSIS 560 0.0050
298 HYPONATRAEMIA 282 0.0050
299 ENTEROCOCCAL INFECTION 24 0.0050
300 HYPOTHERMIA 50 0.0049
301 SINUS TACHYCARDIA 70 0.0049
302 PULMONARY ARTERIAL PRESSURE INCREASED 8 0.0049
303 BREATH SOUNDS ABNORMAL 24 0.0049
304 EXTRAVASATION 20 0.0049
305 RETROPERITONEAL HAEMORRHAGE 12 0.0049
306 NECROSIS 27 0.0048
307 HYPERTHERMIA 37 0.0048
308 DEVICE INFUSION ISSUE 12 0.0048
309 RENAL INFARCT 7 0.0048
310 CAPILLARY LEAK SYNDROME 10 0.0048
311 CARDIAC DYSFUNCTION 18 0.0048
312 SYSTEMIC INFECTION 8 0.0048
313 TACHYARRHYTHMIA 12 0.0048
314 CONSCIOUSNESS FLUCTUATING 5 0.0048
315 HEPATORENAL SYNDROME 8 0.0047
316 TROPONIN T INCREASED 6 0.0047
317 COMA 225 0.0047
318 CARDIAC VENTRICULAR THROMBOSIS 6 0.0046
319 DACRYOSTENOSIS ACQUIRED 6 0.0046
320 BENIGN PROSTATIC HYPERPLASIA 24 0.0046
321 RHABDOMYOLYSIS 193 0.0046
322 INTRA-ABDOMINAL HAEMORRHAGE 11 0.0046
323 DRUG CLEARANCE DECREASED 6 0.0046
324 ARRHYTHMIA SUPRAVENTRICULAR 5 0.0046
325 PNEUMONIA STAPHYLOCOCCAL 9 0.0046
326 NECROTISING FASCIITIS 16 0.0045
327 RETROPERITONEAL HAEMATOMA 10 0.0045
328 NEONATAL RESPIRATORY DISTRESS SYNDROME 16 0.0045
329 BUNDLE BRANCH BLOCK LEFT 19 0.0045
330 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 17 0.0044
331 CYTOKINE RELEASE SYNDROME 89 0.0044
332 HYPERLIPIDAEMIA 53 0.0044
333 CARDIAC TAMPONADE 21 0.0044
334 INTERMITTENT CLAUDICATION 7 0.0044
335 ORTHOPNOEA 14 0.0044
336 CHOLESTASIS 84 0.0044
337 IMMUNE THROMBOCYTOPENIA 20 0.0044
338 DIFFUSE ALVEOLAR DAMAGE 5 0.0043
339 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 238 0.0043
340 BLOOD CALCIUM INCREASED 38 0.0043
341 RESPIRATORY ALKALOSIS 7 0.0043
342 OPTIC ATROPHY 7 0.0043
343 CARDIAC FAILURE ACUTE 28 0.0042
344 PREMATURE BABY 125 0.0041
345 CHRONIC RESPIRATORY FAILURE 5 0.0041
346 TACHYPNOEA 56 0.0041
347 END STAGE RENAL DISEASE 75 0.0041
348 AUTONOMIC NERVOUS SYSTEM IMBALANCE 12 0.0041
349 CARDIOPULMONARY FAILURE 16 0.0041
350 PNEUMONIA FUNGAL 16 0.0041
351 VENOOCCLUSIVE LIVER DISEASE 20 0.0040
352 MULTI-ORGAN FAILURE 70 0.0040
353 NEURALGIA 98 0.0040
354 DRUG LEVEL BELOW THERAPEUTIC 22 0.0040
355 BRAIN OEDEMA 50 0.0040
356 VASCULAR STENT THROMBOSIS 8 0.0039
357 ASPIRATION 43 0.0039
358 HYPERKALAEMIA 137 0.0039
359 TOXICITY TO VARIOUS AGENTS 658 0.0039
360 COAGULATION TIME PROLONGED 6 0.0039
361 SKIN NECROSIS 20 0.0039
362 VENTRICULAR DYSFUNCTION 10 0.0039
363 COLITIS ISCHAEMIC 26 0.0039
364 CLOSTRIDIAL INFECTION 13 0.0038
365 HEART VALVE INCOMPETENCE 11 0.0038
366 DEVICE CONNECTION ISSUE 8 0.0038
367 INHIBITORY DRUG INTERACTION 6 0.0038
368 RALES 22 0.0038
369 PUPILLARY REFLEX IMPAIRED 7 0.0038
370 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 8 0.0038
371 HYPERTRIGLYCERIDAEMIA 22 0.0038
372 ATRIOVENTRICULAR BLOCK 29 0.0037
373 TUMOUR LYSIS SYNDROME 33 0.0037
374 AREFLEXIA 10 0.0037
375 PULMONARY ALVEOLAR HAEMORRHAGE 21 0.0037
376 ATRIOVENTRICULAR BLOCK COMPLETE 25 0.0037
377 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 28 0.0037
378 BACTERAEMIA 44 0.0037
379 BACTERIAL SEPSIS 12 0.0037
380 STAPHYLOCOCCAL BACTERAEMIA 16 0.0037
381 FIBRIN D DIMER INCREASED 13 0.0037
382 CLONUS 10 0.0037
383 BRADYARRHYTHMIA 6 0.0036
384 TYPE IV HYPERSENSITIVITY REACTION 10 0.0036
385 GENERALISED TONIC-CLONIC SEIZURE 60 0.0036
386 PATHOGEN RESISTANCE 33 0.0036
387 ELECTROCARDIOGRAM T WAVE INVERSION 8 0.0036
388 ADRENOCORTICAL INSUFFICIENCY ACUTE 7 0.0036
389 MYOCARDIAL NECROSIS MARKER INCREASED 6 0.0036
390 ACUTE PULMONARY OEDEMA 20 0.0036
391 CELL DEATH 7 0.0035
392 SEDATION COMPLICATION 9 0.0035
393 OXYGEN SATURATION ABNORMAL 10 0.0035
394 CARDIAC FAILURE CHRONIC 15 0.0035
395 BRAIN INJURY 35 0.0035
396 RECALLED PRODUCT 6 0.0035
397 TRANSAMINASES INCREASED 77 0.0035
398 ENCEPHALOPATHY 85 0.0035
399 HEPATIC CYTOLYSIS 44 0.0034
400 LIVER FUNCTION TEST INCREASED 74 0.0034
401 MYDRIASIS 44 0.0034
402 STRIDOR 10 0.0034
403 HYPERBILIRUBINAEMIA 35 0.0034
404 TACHYCARDIA 296 0.0033
405 PULMONARY HAEMORRHAGE 26 0.0033
406 HYPERTRANSAMINASAEMIA 23 0.0033
407 PULMONARY OEDEMA 148 0.0033
408 ESCHERICHIA INFECTION 27 0.0033
409 CONDUCTION DISORDER 6 0.0033
410 ULCER 52 0.0033
411 BUNDLE BRANCH BLOCK RIGHT 15 0.0033
412 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 5 0.0033
413 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 31 0.0032
414 STAPHYLOCOCCAL SEPSIS 16 0.0032
415 DEPRESSED LEVEL OF CONSCIOUSNESS 127 0.0032
416 LEFT VENTRICULAR FAILURE 11 0.0032
417 ACUTE HEPATIC FAILURE 43 0.0031
418 HYPOVOLAEMIC SHOCK 15 0.0031
419 HAEMOLYSIS 24 0.0031
420 ARTERIAL THROMBOSIS 6 0.0031
421 STATUS EPILEPTICUS 35 0.0031
422 ESCHERICHIA URINARY TRACT INFECTION 13 0.0031
423 DRUG LEVEL ABOVE THERAPEUTIC 14 0.0031
424 HEPATITIS FULMINANT 9 0.0030
425 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 10 0.0030
426 NEUROLOGICAL DECOMPENSATION 7 0.0030
427 THERAPY NON-RESPONDER 135 0.0030
428 HYPERAMMONAEMIA 15 0.0030
429 HEPATIC FAILURE 90 0.0030
430 ATRIOVENTRICULAR BLOCK SECOND DEGREE 9 0.0030
431 GOUT 53 0.0030
432 BRAIN NATRIURETIC PEPTIDE INCREASED 9 0.0029
433 POLYCYTHAEMIA 6 0.0029
434 BLOOD LACTATE DEHYDROGENASE INCREASED 46 0.0029
435 ASPERGILLUS INFECTION 19 0.0029
436 BLOOD CHLORIDE INCREASED 5 0.0029
437 ATRIAL FLUTTER 23 0.0029
438 DERMATITIS EXFOLIATIVE GENERALISED 10 0.0029
439 LUNG CONSOLIDATION 8 0.0029
440 MYOCLONUS 34 0.0028
441 INFLAMMATORY MARKER INCREASED 14 0.0028
442 BRONCHIECTASIS 19 0.0028
443 ILEUS 35 0.0028
444 PROCEDURAL HAEMORRHAGE 11 0.0028
445 MYOCARDIAL ISCHAEMIA 32 0.0028
446 ANAEMIA MACROCYTIC 6 0.0028
447 PULMONARY CONGESTION 37 0.0028
448 NEPHROGENIC ANAEMIA 13 0.0028
449 AORTIC VALVE STENOSIS 5 0.0028
450 ATELECTASIS 27 0.0028
451 CANDIDA INFECTION 47 0.0028
452 DEVICE ALARM ISSUE 5 0.0028
453 THROMBOSIS IN DEVICE 9 0.0027
454 URINE OUTPUT DECREASED 24 0.0027
455 HEPATOTOXICITY 61 0.0027
456 MITRAL VALVE INCOMPETENCE 31 0.0027
457 PULMONARY HYPERTENSION 57 0.0027
458 PRODUCT PACKAGING ISSUE 26 0.0027
459 GRAFT VERSUS HOST DISEASE IN SKIN 6 0.0027
460 PSEUDOMEMBRANOUS COLITIS 6 0.0027
461 GASTROINTESTINAL HYPOMOTILITY 6 0.0027
462 NEUTROPENIC SEPSIS 19 0.0027
463 MENTAL STATUS CHANGES 73 0.0026
464 OBSTRUCTIVE AIRWAYS DISORDER 29 0.0026
465 CARDIO-RESPIRATORY ARREST 109 0.0026
466 DRUG LEVEL INCREASED 43 0.0026
467 HAEMANGIOMA 6 0.0026
468 DIASTOLIC DYSFUNCTION 8 0.0026
469 BLOOD POTASSIUM INCREASED 42 0.0026
470 RESPIRATORY DISTRESS 71 0.0026
471 HYPOVOLAEMIA 15 0.0026
472 ACUTE CORONARY SYNDROME 21 0.0025
473 EJECTION FRACTION DECREASED 39 0.0025
474 DELIRIUM 87 0.0025
475 ASPARTATE AMINOTRANSFERASE INCREASED 133 0.0025
476 VENTRICULAR EXTRASYSTOLES 26 0.0025
477 ENDOTRACHEAL INTUBATION 7 0.0025
478 BLOOD TEST ABNORMAL 35 0.0025
479 BLOOD CREATINE INCREASED 11 0.0025
480 PRODUCT PACKAGING CONFUSION 6 0.0025
481 COVID-19 PNEUMONIA 29 0.0025
482 THROMBOCYTOSIS 9 0.0025
483 BLOOD CHOLESTEROL INCREASED 114 0.0024
484 DIVERTICULAR PERFORATION 5 0.0024
485 RASH MACULO-PAPULAR 54 0.0024
486 EUGLYCAEMIC DIABETIC KETOACIDOSIS 10 0.0024
487 GENERAL PHYSICAL HEALTH DETERIORATION 280 0.0024
488 INTRAVENTRICULAR HAEMORRHAGE 6 0.0024
489 ALANINE AMINOTRANSFERASE INCREASED 147 0.0024
490 HEPATIC NECROSIS 9 0.0024
491 DILATATION VENTRICULAR 5 0.0024
492 ABDOMINAL DISTENSION 248 0.0024
493 PROTHROMBIN TIME PROLONGED 14 0.0023
494 DISSEMINATED TUBERCULOSIS 6 0.0023
495 BLOOD CREATININE INCREASED 152 0.0023
496 BLOOD CREATINE PHOSPHOKINASE INCREASED 67 0.0023
497 ANAPHYLACTIC SHOCK 60 0.0023
498 SPUTUM DISCOLOURED 22 0.0023
499 HYPOALBUMINAEMIA 18 0.0023
500 VENOUS THROMBOSIS 9 0.0023
501 PNEUMONIA ASPIRATION 57 0.0023
502 NYSTAGMUS 12 0.0023
503 MULTIPLE-DRUG RESISTANCE 7 0.0023
504 CHOLESTATIC LIVER INJURY 5 0.0022
505 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 117 0.0022
506 ILEUS PARALYTIC 10 0.0022
507 RESPIRATORY RATE DECREASED 7 0.0022
508 NEPHROPATHY TOXIC 25 0.0022
509 EOSINOPHILIA 39 0.0022
510 EOSINOPHILIC PNEUMONIA 7 0.0022
511 INFARCTION 15 0.0022
512 THROMBOCYTOPENIA 245 0.0022
513 PNEUMONIA BACTERIAL 20 0.0022
514 PARADOXICAL DRUG REACTION 8 0.0022
515 AMMONIA INCREASED 11 0.0022
516 PNEUMOTHORAX 34 0.0021
517 HAEMODIALYSIS 18 0.0021
518 DRUG INTERACTION 340 0.0021
519 FOETAL GROWTH RESTRICTION 13 0.0021
520 BLOOD PRESSURE DECREASED 142 0.0021
521 TUMOUR HAEMORRHAGE 6 0.0021
522 UNRESPONSIVE TO STIMULI 54 0.0021
523 SPEECH DISORDER DEVELOPMENTAL 6 0.0021
524 BLOOD UREA INCREASED 35 0.0021
525 PLEURAL EFFUSION 127 0.0021
526 UPPER GASTROINTESTINAL HAEMORRHAGE 35 0.0021
527 ALTERED STATE OF CONSCIOUSNESS 45 0.0021
528 CLOSTRIDIUM DIFFICILE COLITIS 22 0.0021
529 BLOOD BILIRUBIN INCREASED 56 0.0021
530 ESCHERICHIA SEPSIS 6 0.0021
531 SKIN WARM 12 0.0021
532 ADRENAL INSUFFICIENCY 25 0.0021
533 RENAL IMPAIRMENT 173 0.0021
534 FOETAL EXPOSURE DURING PREGNANCY 165 0.0020
535 CREPITATIONS 6 0.0020
536 SMALL FOR DATES BABY 10 0.0020
537 MICTURITION URGENCY 23 0.0020
538 SUICIDE ATTEMPT 122 0.0020
539 HYPERREFLEXIA 7 0.0020
540 MIXED LIVER INJURY 6 0.0020
541 ORGAN FAILURE 8 0.0020
542 JAUNDICE CHOLESTATIC 7 0.0020
543 CONDITION AGGRAVATED 599 0.0020
544 UROSEPSIS 18 0.0019
545 HYPOKALAEMIA 90 0.0019
546 ENDOCARDITIS 10 0.0019
547 PORTAL HYPERTENSION 6 0.0019
548 HYPERCALCAEMIA 24 0.0019
549 CEREBRAL ISCHAEMIA 10 0.0019
550 DRUG INEFFECTIVE 2543 0.0019
551 FOETAL DEATH 10 0.0019
552 PULMONARY EMBOLISM 183 0.0019
553 NERVOUS SYSTEM DISORDER 60 0.0019
554 CONGESTIVE CARDIOMYOPATHY 8 0.0019
555 RENAL FAILURE 253 0.0019
556 ELECTROLYTE IMBALANCE 22 0.0019
557 POST PROCEDURAL HAEMORRHAGE 22 0.0019
558 POOR PERIPHERAL CIRCULATION 8 0.0019
559 SUBARACHNOID HAEMORRHAGE 19 0.0019
560 HAEMOPTYSIS 52 0.0019
561 ANAESTHETIC COMPLICATION 5 0.0019
562 POSTURE ABNORMAL 6 0.0018
563 HYPOVENTILATION 6 0.0018
564 POLYURIA 15 0.0018
565 DERMATITIS BULLOUS 13 0.0018
566 ERYSIPELAS 9 0.0018
567 CORONARY ARTERY STENOSIS 9 0.0018
568 INTENTIONAL PRODUCT MISUSE 156 0.0018
569 GENERALISED OEDEMA 22 0.0018
570 AZOTAEMIA 7 0.0018
571 AUTOIMMUNE HAEMOLYTIC ANAEMIA 6 0.0017
572 ENCEPHALITIS 12 0.0017
573 APLASTIC ANAEMIA 9 0.0017
574 STEVENS-JOHNSON SYNDROME 38 0.0017
575 THROMBOTIC THROMBOCYTOPENIC PURPURA 6 0.0017
576 PRE-ECLAMPSIA 8 0.0017
577 MATERNAL EXPOSURE DURING PREGNANCY 150 0.0017
578 PULMONARY MASS 25 0.0017
579 LIVER INJURY 41 0.0017
580 HYPOGLYCAEMIA 81 0.0017
581 DRY MOUTH 135 0.0017
582 EXPOSURE DURING PREGNANCY 103 0.0017
583 INCORRECT DRUG ADMINISTRATION RATE 7 0.0016
584 THROMBOSIS 131 0.0016
585 TRANSFUSION 17 0.0016
586 INTRACRANIAL PRESSURE INCREASED 9 0.0016
587 CARDIOVASCULAR DISORDER 41 0.0016
588 CHOLANGITIS 10 0.0016
589 HEPATIC FUNCTION ABNORMAL 60 0.0016
590 FULL BLOOD COUNT ABNORMAL 17 0.0016
591 STAPHYLOCOCCAL INFECTION 53 0.0016
592 ANGIOPATHY 9 0.0016
593 HYPOTONIA 16 0.0016
594 NEUROTOXICITY 28 0.0016
595 DECUBITUS ULCER 13 0.0016
596 PNEUMOCYSTIS JIROVECII PNEUMONIA 16 0.0016
597 PULMONARY ARTERIAL HYPERTENSION 23 0.0016
598 LARGE INTESTINE PERFORATION 11 0.0016
599 VENTRICULAR SEPTAL DEFECT 9 0.0016
600 EMBOLISM 13 0.0016
601 AGRANULOCYTOSIS 29 0.0016
602 CLOSTRIDIUM DIFFICILE INFECTION 34 0.0016
603 PERICARDIAL EFFUSION 36 0.0016
604 FEBRILE NEUTROPENIA 103 0.0016
605 DIABETES MELLITUS 118 0.0015
606 RHINOVIRUS INFECTION 6 0.0015
607 BLOOD PRESSURE SYSTOLIC DECREASED 7 0.0015
608 FLUID OVERLOAD 22 0.0015
609 MOUTH HAEMORRHAGE 11 0.0015
610 MUSCLE HAEMORRHAGE 6 0.0015
611 LOWER GASTROINTESTINAL HAEMORRHAGE 11 0.0015
612 MYOCARDITIS 17 0.0015
613 MATERNAL EXPOSURE DURING BREAST FEEDING 6 0.0015
614 NORMAL NEWBORN 8 0.0015
615 ANAPHYLACTOID REACTION 6 0.0015
616 LEG AMPUTATION 6 0.0015
617 HYPERGLYCAEMIA 53 0.0015
618 HYPERCHOLESTEROLAEMIA 14 0.0014
619 PERITONITIS 30 0.0014
620 GUILLAIN-BARRE SYNDROME 7 0.0014
621 OVERDOSE 312 0.0014
622 DRUG RESISTANCE 37 0.0014
623 LIVE BIRTH 12 0.0014
624 ANAPHYLACTIC REACTION 79 0.0014
625 HYPOCALCAEMIA 27 0.0014
626 DUODENAL ULCER 10 0.0014
627 CHOLECYSTITIS ACUTE 8 0.0014
628 AORTIC VALVE INCOMPETENCE 6 0.0014
629 ABDOMINAL TENDERNESS 7 0.0014
630 DIALYSIS 20 0.0014
631 HYPOPHAGIA 36 0.0014
632 PULMONARY TUBERCULOSIS 6 0.0014
633 CARDIAC FAILURE 112 0.0014
634 PRODUCT ADMINISTRATION ERROR 28 0.0014
635 TRICUSPID VALVE INCOMPETENCE 11 0.0014
636 DRUG LEVEL DECREASED 14 0.0014
637 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 7 0.0014
638 BLOOD DISORDER 11 0.0014
639 PRODUCT USE IN UNAPPROVED INDICATION 339 0.0014
640 LUNG INFILTRATION 12 0.0014
641 ACUTE MYOCARDIAL INFARCTION 40 0.0014
642 NEUROLEPTIC MALIGNANT SYNDROME 16 0.0013
643 OFF LABEL USE 1174 0.0013
644 HAEMOLYTIC ANAEMIA 12 0.0013
645 MUSCLE RIGIDITY 16 0.0013
646 HAEMORRHAGE INTRACRANIAL 20 0.0013
647 INTESTINAL PERFORATION 15 0.0013
648 HYPOKINESIA 19 0.0013
649 SLEEP DISORDER 92 0.0013
650 ABDOMINAL PAIN 302 0.0013
651 INTERNATIONAL NORMALISED RATIO INCREASED 37 0.0013
652 ATRIAL FIBRILLATION 125 0.0013
653 HAEMORRHAGIC STROKE 10 0.0013
654 ABORTION INDUCED 12 0.0013
655 LYMPHOPENIA 18 0.0013
656 RENAL FAILURE ACUTE 54 0.0013
657 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 13 0.0013
658 CYTOMEGALOVIRUS INFECTION 21 0.0013
659 HYPERTENSIVE CRISIS 14 0.0013
660 PARALYSIS 18 0.0013
661 PULMONARY FIBROSIS 24 0.0012
662 TRANSPLANT REJECTION 10 0.0012
663 ARRHYTHMIA 59 0.0012
664 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 11 0.0012
665 ANAEMIA 237 0.0012
666 HAEMATOMA 32 0.0012
667 ACCIDENTAL OVERDOSE 45 0.0012
668 SEIZURE 142 0.0012
669 GLOMERULAR FILTRATION RATE DECREASED 15 0.0012
670 PANCYTOPENIA 68 0.0012
671 ENTEROCOLITIS 7 0.0012
672 METABOLIC DISORDER 7 0.0012
673 LEUKOPENIA 60 0.0012
674 TOXIC SKIN ERUPTION 12 0.0012
675 CONJUNCTIVITIS 22 0.0012
676 BODY TEMPERATURE INCREASED 24 0.0012
677 SWELLING 110 0.0012
678 PROCEDURAL COMPLICATION 9 0.0012
679 AGITATION 86 0.0012
680 DIFFUSE LARGE B-CELL LYMPHOMA 9 0.0012
681 HEPATITIS CHOLESTATIC 7 0.0012
682 MYOPATHY 10 0.0012
683 DERMATITIS ACNEIFORM 7 0.0011
684 CEREBRAL INFARCTION 28 0.0011
685 CYANOSIS 18 0.0011
686 CARDIOMEGALY 14 0.0011
687 INJECTION SITE EXTRAVASATION 14 0.0011
688 CYTOMEGALOVIRUS INFECTION REACTIVATION 5 0.0011
689 HEPATOCELLULAR INJURY 16 0.0011
690 INFUSION SITE EXTRAVASATION 7 0.0011
691 JOINT INJURY 24 0.0011
692 CORONARY ARTERY DISEASE 34 0.0011
693 SOMNOLENCE 226 0.0011
694 HEPATOMEGALY 11 0.0011
695 OVERWEIGHT 6 0.0011
696 DRUG INTOLERANCE 107 0.0011
697 CHROMATURIA 25 0.0011
698 HYDROCEPHALUS 6 0.0011
699 CONSTIPATION 239 0.0011
700 ENTERITIS 7 0.0011
701 ACUTE GRAFT VERSUS HOST DISEASE 5 0.0011
702 BLOOD ALKALINE PHOSPHATASE INCREASED 27 0.0011
703 HEPATIC ENCEPHALOPATHY 10 0.0011
704 UPPER RESPIRATORY TRACT INFECTION 49 0.0011
705 HAEMATOCRIT DECREASED 21 0.0011
706 PRODUCT PRESCRIBING ISSUE 23 0.0011
707 HYPERTONIA 6 0.0010
708 MELAENA 23 0.0010
709 MOUTH ULCERATION 22 0.0010
710 JAUNDICE 28 0.0010
711 LIVER DISORDER 46 0.0010
712 CONGENITAL ANOMALY 8 0.0010
713 PRODUCT LABEL CONFUSION 6 0.0010
714 PNEUMONITIS 28 0.0010
715 PURPURA 9 0.0010
716 RESPIRATION ABNORMAL 7 0.0010
717 RESPIRATORY RATE INCREASED 9 0.0010
718 LOWER RESPIRATORY TRACT INFECTION 46 0.0010
719 ISCHAEMIC STROKE 18 0.0010
720 BLOOD ALBUMIN DECREASED 8 0.0010
721 HYPOMAGNESAEMIA 14 0.0010
722 EXTRASYSTOLES 7 0.0010
723 PNEUMONIA 323 0.0010
724 INGUINAL HERNIA 6 0.0010
725 MALNUTRITION 11 0.0010
726 GASTROINTESTINAL HAEMORRHAGE 82 0.0010
727 BRONCHOSPASM 14 0.0010
728 BLISTER 55 0.0010
729 SUBDURAL HAEMATOMA 14 0.0010
730 RESPIRATORY DISORDER 29 0.0010
731 C-REACTIVE PROTEIN INCREASED 35 0.0010
732 POST PROCEDURAL COMPLICATION 18 0.0009
733 HERPES SIMPLEX 6 0.0009
734 OXYGEN SATURATION DECREASED 51 0.0009
735 DEAFNESS UNILATERAL 5 0.0009
736 LUNG INFECTION 14 0.0009
737 GASTRIC ULCER 17 0.0009
738 CEREBRAL HAEMORRHAGE 32 0.0009
739 MYOSITIS 8 0.0009
740 PLATELET COUNT DECREASED 95 0.0009
741 REBOUND EFFECT 10 0.0009
742 ABNORMAL LOSS OF WEIGHT 6 0.0009
743 LUNG DISORDER 43 0.0009
744 ECCHYMOSIS 6 0.0009
745 PERIPHERAL COLDNESS 12 0.0009
746 SPINAL PAIN 10 0.0009
747 ARTERIOSCLEROSIS 8 0.0008
748 DRUG ERUPTION 15 0.0008
749 PANCREATITIS ACUTE 19 0.0008
750 ATRIAL SEPTAL DEFECT 7 0.0008
751 POLYNEUROPATHY 10 0.0008
752 CHRONIC KIDNEY DISEASE 63 0.0008
753 DRUG-INDUCED LIVER INJURY 26 0.0008
754 HAEMORRHAGE 86 0.0008
755 COLITIS 31 0.0008
756 LETHARGY 47 0.0008
757 GAMMA-GLUTAMYLTRANSFERASE INCREASED 18 0.0008
758 DRUG DIVERSION 5 0.0008
759 TREATMENT FAILURE 67 0.0008
760 NEUTROPHIL COUNT DECREASED 32 0.0008
761 MOTOR DYSFUNCTION 8 0.0008
762 RENAL INJURY 23 0.0008
763 PALLOR 21 0.0008
764 HAEMOGLOBIN DECREASED 79 0.0008
765 HYPERTENSION 162 0.0008
766 PYREXIA 264 0.0008
767 IRON DEFICIENCY ANAEMIA 7 0.0008
768 CHOLECYSTITIS 9 0.0008
769 GASTROENTERITIS 11 0.0008
770 ERYTHEMA MULTIFORME 7 0.0007
771 VOMITING 346 0.0007
772 CYTOPENIA 9 0.0007
773 ASPHYXIA 6 0.0007
774 HEMIPLEGIA 6 0.0007
775 HEPATIC ENZYME INCREASED 49 0.0007
776 DISEASE PROGRESSION 85 0.0007
777 TRANSIENT ISCHAEMIC ATTACK 24 0.0007
778 THERAPY PARTIAL RESPONDER 11 0.0007
779 BLOOD PRESSURE ABNORMAL 14 0.0007
780 TUBULOINTERSTITIAL NEPHRITIS 13 0.0007
781 CONTRAINDICATED PRODUCT ADMINISTERED 21 0.0007
782 PYELONEPHRITIS 6 0.0007
783 LIVER FUNCTION TEST ABNORMAL 20 0.0007
784 ORAL CANDIDIASIS 9 0.0007
785 LYMPHOCYTE COUNT DECREASED 12 0.0007
786 ANGIOEDEMA 30 0.0007
787 HAEMATEMESIS 17 0.0007
788 OPTIC NEURITIS 6 0.0007
789 WHITE BLOOD CELL COUNT INCREASED 25 0.0007
790 SMALL INTESTINAL OBSTRUCTION 8 0.0006
791 PANCREATITIS 34 0.0006
792 APNOEA 5 0.0006
793 NEUTROPENIA 87 0.0006
794 DEEP VEIN THROMBOSIS 41 0.0006
795 OBESITY 10 0.0006
796 OEDEMA PERIPHERAL 75 0.0006
797 HAEMATURIA 21 0.0006
798 ABNORMAL FAECES 5 0.0006
799 DRUG WITHDRAWAL SYNDROME NEONATAL 9 0.0006
800 SARS-COV-2 TEST POSITIVE 8 0.0006
801 VASCULITIS 7 0.0006
802 SKIN DISORDER 20 0.0006
803 OEDEMA 32 0.0006
804 ATAXIA 7 0.0006
805 DIABETIC KETOACIDOSIS 14 0.0006
806 FUNGAL INFECTION 19 0.0006
807 INCONTINENCE 6 0.0006
808 ORAL HERPES 11 0.0006
809 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
810 HEART RATE INCREASED 54 0.0005
811 RESPIRATORY ARREST 15 0.0005
812 SKIN DISCOLOURATION 25 0.0005
813 RASH ERYTHEMATOUS 26 0.0005
814 CELLULITIS 27 0.0005
815 HEMIPARESIS 9 0.0005
816 DEVICE FAILURE 8 0.0005
817 EPILEPSY 16 0.0005
818 LOSS OF CONSCIOUSNESS 67 0.0005
819 GASTRIC HAEMORRHAGE 6 0.0005
820 CAESAREAN SECTION 6 0.0005
821 ACUTE MYELOID LEUKAEMIA 8 0.0005
822 GINGIVAL BLEEDING 7 0.0005
823 HEART RATE DECREASED 18 0.0005
824 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
825 HEPATITIS 13 0.0005
826 DISEASE RECURRENCE 24 0.0005
827 INFLAMMATION 26 0.0005
828 BLOOD POTASSIUM DECREASED 15 0.0005
829 BONE MARROW FAILURE 10 0.0005
830 IMMUNODEFICIENCY 7 0.0005
831 HIATUS HERNIA 6 0.0005
832 PLATELET COUNT INCREASED 6 0.0005
833 DYSPNOEA 259 0.0005
834 INTENTIONAL PRODUCT USE ISSUE 40 0.0005
835 DEVICE RELATED INFECTION 7 0.0005
836 COGNITIVE DISORDER 21 0.0004
837 URINARY RETENTION 15 0.0004
838 BLOOD CALCIUM DECREASED 5 0.0004
839 COMPLETED SUICIDE 37 0.0004
840 COVID-19 77 0.0004
841 RESTLESSNESS 16 0.0004
842 MEDICATION ERROR 24 0.0004
843 COORDINATION ABNORMAL 6 0.0004
844 RASH MACULAR 15 0.0004
845 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
846 FACE OEDEMA 7 0.0004
847 MYELODYSPLASTIC SYNDROME 6 0.0004
848 HYPERTHYROIDISM 6 0.0004
849 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
850 MUSCULOSKELETAL STIFFNESS 36 0.0004
851 NO ADVERSE EVENT 73 0.0004
852 INTESTINAL OBSTRUCTION 15 0.0004
853 GASTROOESOPHAGEAL REFLUX DISEASE 32 0.0004
854 APHASIA 12 0.0004
855 NAUSEA 311 0.0004
856 MYELOSUPPRESSION 14 0.0004
857 CARDIAC FAILURE CONGESTIVE 31 0.0004
858 DERMATITIS 8 0.0004
859 WITHDRAWAL SYNDROME 16 0.0004
860 CONFUSIONAL STATE 61 0.0004
861 DYSARTHRIA 14 0.0004
862 BLOOD SODIUM DECREASED 7 0.0004
863 WHEEZING 22 0.0004
864 DEATH 318 0.0004
865 PRODUCT USE ISSUE 68 0.0004
866 HYPERHIDROSIS 46 0.0004
867 RED BLOOD CELL COUNT DECREASED 10 0.0003
868 FEEDING DISORDER 7 0.0003
869 HYPOTHYROIDISM 11 0.0003
870 MUCOSAL INFLAMMATION 9 0.0003
871 PRODUCT PREPARATION ERROR 7 0.0003
872 SYNCOPE 34 0.0003
873 PRODUCT PRESCRIBING ERROR 8 0.0003
874 TREMOR 55 0.0003
875 INTERSTITIAL LUNG DISEASE 16 0.0003
876 TREATMENT NONCOMPLIANCE 18 0.0003
877 ASTHMA 37 0.0003
878 DRUG ABUSE 27 0.0003
879 HEPATIC STEATOSIS 6 0.0003
880 ABSCESS 5 0.0003
881 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
882 THERAPEUTIC RESPONSE DECREASED 18 0.0003
883 EPISTAXIS 22 0.0003
884 PRODUCTIVE COUGH 14 0.0003
885 URINARY TRACT INFECTION 50 0.0003
886 THERAPY CESSATION 15 0.0003
887 INFECTION 42 0.0003
888 MENTAL IMPAIRMENT 7 0.0003
889 DYSPHAGIA 27 0.0003
890 GASTROINTESTINAL DISORDER 25 0.0003
891 DISORIENTATION 11 0.0003
892 CHOLELITHIASIS 9 0.0003
893 SKIN EXFOLIATION 23 0.0003
894 BLINDNESS 11 0.0003
895 SEDATION 7 0.0003
896 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
897 CHILLS 31 0.0003
898 MUSCLE TWITCHING 6 0.0003
899 NIGHTMARE 9 0.0003
900 INFUSION RELATED REACTION 17 0.0003
901 SWOLLEN TONGUE 8 0.0003
902 HAEMATOCHEZIA 14 0.0003
903 MENTAL DISORDER 11 0.0003
904 EXTRA DOSE ADMINISTERED 10 0.0002
905 ASTHENIA 92 0.0002
906 AGGRESSION 12 0.0002
907 HALLUCINATION 18 0.0002
908 MUSCULAR WEAKNESS 27 0.0002
909 ERYTHEMA 48 0.0002
910 RESPIRATORY TRACT INFECTION 6 0.0002
911 DRUG ADMINISTRATION ERROR 7 0.0002
912 EMOTIONAL DISORDER 7 0.0002
913 DEHYDRATION 30 0.0002
914 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
915 RENAL DISORDER 10 0.0002
916 DYSPNOEA EXERTIONAL 8 0.0002
917 WHITE BLOOD CELL COUNT DECREASED 23 0.0002
918 PAIN IN JAW 6 0.0002
919 CEREBROVASCULAR ACCIDENT 35 0.0002
920 RASH 90 0.0002
921 COUGH 57 0.0002
922 PSYCHOTIC DISORDER 6 0.0002
923 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 35 0.0002
924 ACCIDENTAL EXPOSURE TO PRODUCT 20 0.0002
925 UNDERDOSE 14 0.0002
926 INCORRECT DOSE ADMINISTERED 43 0.0002
927 RECTAL HAEMORRHAGE 8 0.0002
928 DISTURBANCE IN ATTENTION 10 0.0002
929 MYOCARDIAL INFARCTION 32 0.0002
930 DRUG WITHDRAWAL SYNDROME 16 0.0002
931 DIARRHOEA 117 0.0002
932 CHEST PAIN 33 0.0002
933 HYPERSENSITIVITY 33 0.0002
934 FLUID RETENTION 9 0.0002
935 CONVULSION 10 0.0002
936 URTICARIA 27 0.0002
937 CYSTITIS 5 0.0002
938 MALIGNANT NEOPLASM PROGRESSION 16 0.0002
939 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
940 SUICIDAL IDEATION 14 0.0002
941 SPEECH DISORDER 8 0.0002
942 STOMATITIS 9 0.0001
943 ABDOMINAL PAIN UPPER 30 0.0001
944 MYALGIA 24 0.0001
945 ECZEMA 7 0.0001
946 NEPHROLITHIASIS 6 0.0001
947 DEVICE MALFUNCTION 9 0.0001
948 THERAPY INTERRUPTED 9 0.0001
949 AMNESIA 8 0.0001
950 DECREASED APPETITE 28 0.0001
951 CARDIAC DISORDER 11 0.0001
952 DRUG DOSE OMISSION BY DEVICE 9 0.0001
953 DEPRESSED MOOD 6 0.0001
954 MALAISE 48 0.0001
955 FLUSHING 11 0.0001
956 CHEST DISCOMFORT 11 0.0001
957 PAIN 63 0.0001
958 SURGERY 6 0.0001
959 FALL 34 0.0001
960 DISCOMFORT 6 0.0001
961 DIZZINESS 49 0.0001
962 FATIGUE 75 0.0001
963 NEUROPATHY PERIPHERAL 9 0.0001
964 PALPITATIONS 11 0.0001
965 CONTUSION 9 0.0001
966 PRODUCT DOSE OMISSION ISSUE 27 0.0001
967 BLOOD PRESSURE INCREASED 14 0.0001
968 ANXIETY 26 0.0001
969 HEADACHE 56 0.0001
970 VISUAL IMPAIRMENT 11 0.0001
971 MUSCLE SPASMS 16 0.0001
972 MOBILITY DECREASED 6 0.0001
973 PARAESTHESIA 13 0.0001
974 PRODUCT QUALITY ISSUE 11 0.0001
975 BLOOD GLUCOSE INCREASED 15 0.0001
976 PRURITUS 30 0.0001
977 PERIPHERAL SWELLING 12 0.0001
978 ABDOMINAL DISCOMFORT 12 0.0001
979 DEVICE ISSUE 6 0.0001
980 INSOMNIA 17 0.0001
981 INFLUENZA 7 0.0001
982 DYSPEPSIA 6 0.0001
983 ADVERSE EVENT 5 0.0001
984 ARTHRALGIA 21 0.0001
985 WEIGHT DECREASED 14 0.0001
986 DRUG DEPENDENCE 8 0.0000
987 BACK PAIN 11 0.0000
988 GAIT DISTURBANCE 9 0.0000
989 PAIN IN EXTREMITY 13 0.0000
990 WEIGHT INCREASED 9 0.0000
991 DEPRESSION 9 0.0000
992 HOSPITALISATION 6 0.0000
993 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
994 NASOPHARYNGITIS 6 0.0000
995 ALOPECIA 6 0.0000